p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape-Reference-Cited by-同舟云学术

p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape

Published:2008 Issue:10 Volume:68 Page:1097-1104
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Isharwal Sumit,Miller Michael C.,Marlow Cameron,Makarov Danil V.,Partin Alan W.,Veltri Robert W.

Publisher

Wiley

Subject

Urology,Oncology

Reference58 articles.

1. Natural History of Progression After PSA Elevation Following Radical Prostatectomy

2. Biochemical (Prostate Specific Antigen) Recurrence Probability Following Radical Prostatectomy for Clinically Localized Prostate Cancer

3. Pathological and molecular aspects of prostate cancer

4. Prostate Cancer

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive Characterization of HATs and HDACs in Human Cancers Reveals Their Role in Immune Checkpoint Blockade;Critical Reviews in Eukaryotic Gene Expression;2024

2. Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer;Cancer Cell;2023-08

3. Cholesterol Triggers Nuclear Co-Association of Androgen Receptor, p160 Steroid Coactivators, and p300/CBP-Associated Factor Leading to Androgenic Axis Transactivation in Castration-Resistant Prostate Cancer;Cellular Physiology and Biochemistry;2022-12-02

4. Advances of Epigenetic Biomarkers and Epigenome Editing for Early Diagnosis in Breast Cancer;International Journal of Molecular Sciences;2022-08-23

5. Targeting the p300/CBP Axis in Lethal Prostate Cancer;Cancer Discovery;2021-01-11